ASTHMAXcel Voice Study
Conducting a Randomized Controlled Trial for A Novel Patient-Facing Mobile Platform to Collect and Implement Patient-Reported Outcomes and Voice Biomarkers in Underserved Adult Patients With Asthma
Montefiore Medical Center
200 participants
Sep 18, 2025
INTERVENTIONAL
Conditions
Summary
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
Eligibility
Inclusion Criteria4
- English speaking
- Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication
- Able to provide informed consent
- Smartphone access (iOS or Android) with data plan
Exclusion Criteria2
- Pregnancy
- Severe psychiatric or cognitive problems that would prohibit completion of protocol
Interventions
ASTHMAXcel Voice is a mobile health application with a multi-level approach to address barriers with intervention components and facilitate health behavior change through the use of push notifications and interactive educational content.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06935084